TOP TIERMARKET NEWSWIRE
SEC Form 4 history

TRAVERE THERAPEUTICS (TVTX) insider trades

TRAVERE THERAPEUTICS (TVTX) insider trading activity (SEC Form 4). Over the trailing 90 days, TVTX insiders filed 0 purchases totalling $0 and 10 sales totalling $67.0M — net SELLING of $67.0M. Most recent filing: Sep 17, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
10
$67.0M
Net (90d)
-$67.0M
net selling
Most recent
Sep 17, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 17, 2026Rote William E.Chief Research OfficerS SaleOE—$62.83$13.1Mfiling
Sep 17, 2026Heerma PeterEVP, CHIEF COMMERCIAL OFFICERS SaleOE—$63.06$17.9Mfiling
Sep 17, 2026Inrig JulaEVP, Head of R, D, CMOS SaleOE—$62.34$2.8Mfiling
Sep 17, 2026Reed Elizabeth EGC, GCS SaleOE—$62.34$2.3Mfiling
Sep 17, 2026Dube Eric MCEOS SaleOE—$63.48$25.4Mfiling
Sep 17, 2026Cline Christopher R.CFOS SaleOE—$62.34$3.1Mfiling
Sep 17, 2026Calvin SandraSVP, Chief Accounting OfficerS SaleOE—$62.33$335Kfiling
Sep 11, 2026Meckler Jeffrey ADirS SaleOE—$67.31$1.3Mfiling
Sep 3, 2026Cline Christopher R.CFOS Sale—$66.37$43Kfiling
Aug 19, 2026Lyons Gary ADirS SaleOE—$63.28$633Kfiling
Jun 16, 2026Coughlin TimothyDirS SaleOE—$50.07$501Kfiling
Jun 16, 2026Baynes Roy D.DirS SaleOE—$50.00$225Kfiling
May 19, 2026Coughlin TimothyDirS Sale—$43.49$141Kfiling